We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CCM

News List

Concord Medical Reports Financial Results for the First Half of 2020 prnasia
August 26, 2020
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalo
Recommendations Decreased for Cough, Cold Medicine in U.S. drugs
August 02, 2019
There has been a decrease in recommendations for opioid-containing and nonopioid cough and cold medicines (CCM) in the United States...
Recursion Receives FDA Clearance for REC-994 Clinical Trial americanpharmaceuticalreview
July 11, 2018
Recursion announced the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a Phase 1 clinical trial of REC-994 in the treatment of cerebral cavernous malformation (CCM).